A groundbreaking FDA approval offers the first-ever treatment for ultra-rare Thymidine Kinase 2 Deficiency (TK2d). KYGEVVI, a ...
Mitochondria are the small organelles that generate the energy our bodies need to grow, move, and stay healthy. As ...
FDA approves first drug for TK2 deficiency, giving hope to patients with rare mitochondrial disorder
In a historic medical breakthrough, the US Food and Drug Administration (FDA) has approved KYGEVVI—a combination of ...
Scientists uncovered how the amino acid leucine enhances mitochondrial efficiency by preserving crucial proteins that drive ...
A new study led by Swansea University has revealed a new way to potentially treat certain autoimmune diseases by targeting a ...
Major surgery is associated with transient suppression of T-cell immunity, increasing susceptibility to severe infections. This study identifies a previously unrecognized mechanism that drives ...
A team led by the UAB Institut de Neurociències (INc-UAB) has for the first time identified the mechanism behind a ...
Tisento Therapeutics today announced that the findings from the company’s interview study in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes) were published on ...
9d
Mitolyn Launches Consumer Education Initiative on Natural Mitochondrial Support Ingredients for 2025
Company Releases Comprehensive Ingredient Research Guide to Address Consumer Confusion in Growing Metabolic Health Supplement ...
During the SupplySide Global event in Las Vegas, Kaneka Nutrients, a leading dietary ingredient manufacturer, will explore the latest scientific breakthroughs in mitochondrial function, cellular ...
BackgroundSepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and multi-organ dysfunction. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback